apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Staurinz 25 mg Softgel Capsule 28's

Staurinz 25 mg Softgel Capsule 28's, Pack of 1 CAPSULE
Offers on medicine orders
All offers
axis icici
Written By Santoshini Reddy G , M Pharmacy
Reviewed By Lakshmithulasi Yarragunta ,

Staurinz 25 mg Softgel Capsule is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), or mast cell leukaemia (MCL). It contains Midostaurin, which works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells. This medicine is not recommended for children as safety and effectiveness have not been established.

Read more
rxMedicinePrescription drug

Whats That

tooltip

Also Explore

Momverse
Ask Apollo
insurance

Composition :

MIDOSTAURIN-25MG

Manufacturer/Marketer :

Dr Reddy's Laboratories Ltd

Consume Type :

ORAL

Return Policy :

Not Returnable

Expires on or after :

About Staurinz 25 mg Softgel Capsule

Staurinz 25 mg Softgel Capsule belongs to the group of medicines called protein kinase inhibitors used to treat acute myeloid leukaemia (AML). It is sometimes, also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), or mast cell leukaemia (MCL).

Staurinz 25 mg Softgel Capsule contains Midostaurin, which works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells.

Staurinz 25 mg Softgel Capsule may cause certain side effects such as nausea, vomiting, headache, fever, musculoskeletal pain, and upper abdominal pain. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen. Take Staurinz 25 mg Softgel Capsule as prescribed by your doctor.

Discontinue taking Staurinz 25 mg Softgel Capsule and inform your physician if you observe any allergic reactions. Inform the doctor about your health condition and medications to rule out any side effects. Do not take Staurinz 25 mg Softgel Capsule if you are pregnant or breastfeeding. This medicine is not recommended for children as safety and effectiveness have not been established.

Uses of Staurinz 25 mg Softgel Capsule

Staurinz 25 mg Softgel Capsule is used in the treatment of Acute myeloid leukaemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), and mast cell leukaemia (MCL). The detailed uses of Staurinz 25 mg Softgel Capsule are as follows:<br/>• Treatment of FLT3-Mutated Acute Myeloid Leukemia (AML): Staurinz 25 mg Softgel Capsule is used in combination with standard chemotherapy (cytarabine and daunorubicin) to treat newly diagnosed AML in adults who test positive for FLT3 mutations.<br/>• Management of Advanced Systemic Mastocytosis (ASM): Staurinz 25 mg Softgel Capsule helps reduce the proliferation of abnormal mast cells in patients with aggressive systemic mastocytosis, improving symptoms and slowing disease progression.<br/>• Therapy for Mast Cell Leukemia (MCL) and SM-AHN: Staurinz 25 mg Softgel Capsule is used for rare blood disorders like mast cell leukemia and systemic mastocytosis with associated hematologic neoplasm, targeting abnormal cell growth in bone marrow and blood.<br/>• Tyrosine Kinase Inhibition Mechanism: Staurinz 25 mg Softgel Capsule works by blocking multiple kinases, including FLT3, which are involved in cancer cell growth and survival, making it effective against certain hematologic malignancies.<br/>

Directions for Use

• Recommended to take Staurinz 25 mg Softgel Capsule with food to prevent stomach upset.• Recommended to take twice daily or as advised by your doctor.• Swallow the medicine as a whole with glass of water.• Do not crush, break, or chew it.

Medicinal Benefits

Staurinz 25 mg Softgel Capsule belongs to the group of medicines called protein kinase inhibitors used to treat acute myeloid leukaemia (AML) in patients who are FLT3 mutation-positive. It is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), or mast cell leukaemia (MCL). Staurinz 25 mg Softgel Capsule contains Midostaurin, which works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells.

How Staurinz 25 mg Softgel Capsule Works

Staurinz 25 mg Softgel Capsule contains Midostaurin, which works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells.

Storage

• Store in a cool and dry place away from sunlight.
• Keep Staurinz 25 mg Softgel Capsule out of reach and sight of children.
• Non cold chain - To be stored in cool places at 10ºC to 25ºC or below 30ºC.

What if I have taken an overdose of Staurinz 25 mg Softgel Capsule

Please do not exceed the recommended dose, as it might cause an overdose. Signs and symptoms of an overdose of Staurinz 25 mg Softgel Capsule may include feeling cold, goosebumps, increased blood pressure (headache, flushing, blurred vision, pounding heartbeat) and trouble urinating. Seek immediate medical attention if you observe these symptoms or think you might have taken too much. Do this even if there are no signs of discomfort or poisoning.

Drug Warnings

Do not take Staurinz 25 mg Softgel Capsule if you are allergic to any of its components, if you are taking medicines used to treat tuberculosis (rifampicin), epilepsy (carbamazepine or phenytoin), prostate cancer (enzalutamide), or herbal products (St. John’s Wort) or if you are pregnant or breastfeeding. Inform the doctor if you have any infections, heart disorders, lung, kidney or liver diseases. Seek immediate medical attention if you experience symptoms of low white blood cell count (fever, sore throat, mouth ulcers), lung problems (fever, chest pain, cough with or without mucous, trouble breathing or shortness of breath), or heart problems (chest pain or discomfort, fainting, dizziness, light-headedness, shortness of breath, blue discolouration of your lips, hands or feet, or swelling of your lower limbs).

Diet & Lifestyle Advise

  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Avoid smoking and alcohol consumption.
  • Include vegetables and fruits in your diet.
  • Avoid fast food, fried food, processed meats, refined carbs and added sugar.
  • Get optimal sleep; rest well.
  • Drink enough water to stay hydrated.

Habit Forming

No

Therapeutic Class

KINASE INHIBITORS

Staurinz 25 mg Softgel Capsule Substitute

Substitutes safety advice

Product Substitutes

bannner image

Alcohol

Consult your doctor

It is not known if alcohol affects Staurinz 25 mg Softgel Capsule . Please consult your doctor.

bannner image

Pregnancy

Unsafe

Staurinz 25 mg Softgel Capsule is not recommended during pregnancy as it may harm your unborn baby. Therefore, if you are pregnant or planning for pregnancy, talk to the doctor for advice.

bannner image

Breast Feeding

Unsafe

Staurinz 25 mg Softgel Capsule may harm the baby. Avoid breastfeeding during treatment with Staurinz 25 mg Softgel Capsule and for at least 4 months after stopping the treatment.

bannner image

Driving

Caution

Staurinz 25 mg Softgel Capsule may cause dizziness and vertigo. Be cautious while driving or operating machinery.

bannner image

Liver

Consult your doctor

If you have a pre-existing or a history of liver disease, inform your doctor before receiving Staurinz 25 mg Softgel Capsule . Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Kidney

Consult your doctor

If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Staurinz 25 mg Softgel Capsule . Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Children

Caution

The safety and effectiveness of Staurinz 25 mg Softgel Capsule in children below 18 years have not been established.

Have a query?

FAQs

Staurinz 25 mg Softgel Capsule is used to treat Acute myeloid leukaemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), and mast cell leukaemia (MCL).

Staurinz 25 mg Softgel Capsule works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells.

If you miss a dose of Staurinz 25 mg Softgel Capsule , take your next dose at the scheduled time. Avoid taking an extra dose to make up for the missed dose.

Staurinz 25 mg Softgel Capsule may reduce fertility in men and women. Before starting the treatment, discuss with the doctor if you have any concerns regarding fertility.

Continue taking Staurinz 25 mg Softgel Capsule even if you feel well. Do not stop taking Staurinz 25 mg Softgel Capsule without talking to the doctor.

If you vomit after taking Staurinz 25 mg Softgel Capsule , do take another dose. Continue with your regular dosing schedule and take the next dose at your scheduled time. If nausea or vomiting persists or worsens, consult the doctor.

Country of origin

India

Manufacturer/Marketer address

Dr. Reddy'S Laboratories Ltd., 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500034, India
Other Info - STA0963

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Author Details

Santoshini Reddy GDoctor badge

Written By

Santoshini Reddy G

M Pharmacy

Last Updated

Jul 18, 2025 | 9:22 AM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

Reference

  1. https://www.medicines.org.uk/emc/files/pil.9134.pdf
  2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207997s000lbl.pdf
  3. https://medlineplus.gov/druginfo/meds/a617033.html
  4. https://www.drugs.com/mtm/midostaurin.html
  5. https://www.novartis.com/sg-en/sites/novartis_sg/files/Rydapt-Mar2021.SIN-App280721.pdf

Buy best Neoplastic Disorders products by

whatsapp Floating Button